[D-penicillamine nephropathy].
Ohno
I
I
Second Department of Internal Medicine, Jikei University School of Medicine.
D000293:Adolescent; D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects*; D002614:Chelating Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D010396:Penicillamine / Q000009:adverse effects*
D018501:Antirheumatic Agents; D002614:Chelating Agents; D010396:Penicillamine